VITASIRO
Live / Registered — Registered (as of 27 Feb 2024)
What this means for you
Registered since 27 Feb 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97621542
- Registration number
- 7313687
- Mark type
- Stylized text
- Filed
- 06 Oct 2022
- Published for opposition
- 12 Dec 2023
- Registered
- 27 Feb 2024
- Attorney of record
- Nicole B. Rackiewicz
Goods and services
- Class 001 — Chemicals: Biological preparations, other than for medical or veterinary purposes, namely, for use in industry and science; Chemical preparations for use in science; Reagents for use in scientific apparatus for chemical analyses; Chemical reagents, other than for medical or veterinary purposes; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Reagents for scientific purposes; Chemical reagents for scientific purposes; Reagents for in-vitro laboratory use, other than for medical or veterinary purposes; Magnetic fluid for industrial purposes; Diagnostic preparations for laboratory use, other than for medical or veterinary purposes; Nucleic acid amplification reagents for scientific purposes; Nucleic acid extraction reagents for scientific purposes; Nucleic acid detection reagents for scientific purposes
- Class 005 — Pharmaceuticals: Diagnostic biomarker reagents for medical purposes; Diagnostic preparations for veterinary purposes; Diagnostic preparations for medical purposes; Chemical reagent mixtures in kit form for medical use, namely, in-vitro diagnostic (IVD) disease testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Diagnostic reagents for medical use for sale in kit form, namely, in-vitro diagnostic (IVD) kits consisting primarily of primers, probes, polymerases, buffers, and reagents for use in disease testing by sample preparation, nucleic acid purification and amplification, and optical detection; Nucleic acid amplification reagents for medical use; Nucleic acid extraction reagents for medical use; Nucleic acid detection reagents for medical use
- Class 009 — Scientific and electric apparatus: Test tubes; Precision measuring apparatus, namely, Polymerase chain reaction (PCR) apparatus, namely, a spectrophotometer for measuring the DNA and RNA level of the susceptible body fluids; Apparatus for scientific research in laboratories, namely, apparatus for extracting the DNA and RNA from the susceptible body fluids; Apparatus for use in laboratory analysis, namely, apparatus for extracting the DNA and RNA from the susceptible body fluids; Bioreactors for laboratory use; Cartridges for scientific use in nucleic acid extraction and amplification and detection
- Class 010 — Medical apparatus: Veterinary apparatus and instruments, namely, veterinary diagnostic apparatus for testing the DNA and RNA level of pathogens and other biological tissues; Diagnostic apparatus for medical purposes for testing the DNA and RNA level of pathogens and other biological tissues; Test equipment for medical use, namely, medical test equipment for bioanalysis of body fluids incorporating a cartridge for sample preparation, nucleic acid purification and amplification, and optical detection
Owner
- Credo Diagnostics Biomedical Pte. Ltd., Singapore, SG
- Credo Diagnostics Biomedical Pte. Ltd., Singapore, SG
- Credo Diagnostics Biomedical Pte. Ltd., Singapore, SG
Prior registrations
Prosecution history
- 27 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 12 Dec 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Dec 2023 — PUBLISHED FOR OPPOSITION
- 22 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Nov 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Nov 2023 — EXAMINER'S AMENDMENT ENTERED
- 02 Nov 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 02 Nov 2023 — EXAMINERS AMENDMENT E-MAILED
- 02 Nov 2023 — EXAMINERS AMENDMENT -WRITTEN
- 19 Oct 2023 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 19 Oct 2023 — FINAL REFUSAL E-MAILED
- 19 Oct 2023 — FINAL REFUSAL WRITTEN
- 14 Sept 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Sept 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE